Zobrazeno 1 - 10
of 1 048
pro vyhledávání: '"tedizolid"'
Autor:
Masahiro Toyokawa, Noboru Ohana, Daiki Tanno, Minako Imai, Yukiko Takano, Kazutaka Ohashi, Tomonari Yamashita, Kyoichi Saito, Hiroki Takahashi, Hiroki Shimura
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The purpose of the present study was to evaluate the in vitro activity of tedizolid against several clinically significant species of Nocardia by comparing with that of linezolid. A total of 286 isolates of Nocardia species, including 236 cl
Externí odkaz:
https://doaj.org/article/3f7323d089fd49e3a8ceddcd89d5e708
Autor:
Moritz Staudacher, Julian Frederic Hotz, Richard Kriz, Katharina Schefberger, Lisa Schneider, Kathrin Spettel, Peter Starzengruber, Jürgen Benjamin Hagemann, Amelie Leutzendorff, Heinz Burgmann, Heimo Lagler
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTInvasive Staphylococcus aureus infections are associated with a high burden of disease, case fatality rate and healthcare costs. Oxazolidinones such as linezolid and tedizolid are considered potential treatment choices for conditions involvin
Externí odkaz:
https://doaj.org/article/fa512814fe9043f89803187941e28b7f
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background Tedizolid is an oxazolidinone anti-MRSA drug with included in the National Health Insurance Drug Price List in 2018. The effect of hemodialysis on tedizolid phosphate concentrations has been reported; pre-dialysis concentrations d
Externí odkaz:
https://doaj.org/article/11201b7687b849d78d6363052275464b
Publikováno v:
Pharmaceutics, Vol 16, Iss 6, p 818 (2024)
Multidrug-resistant tuberculosis (MDR-TB) is a global health concern. Standard treatment involves the use of linezolid, a repurposed oxazolidinone. It is associated with severe adverse effects, including myelosuppression and mitochondrial toxicity. A
Externí odkaz:
https://doaj.org/article/2669d17c00f048fb9977a6e613b8ad20
Autor:
Loren G. Miller, Evelyn A. Flores, Bryn Launer, Pamela Lee, Praneet Kalkat, Kelli Derrah, Shalini Agrawal, Matthew Schwartz, Grant Steele, Tae Kim, Maita S. Kuvhenguhwa
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 5 (2023)
ABSTRACT Bone and joint infections (BJIs) are common infections increasingly managed with oral therapy. However, there are limited safe oral options for many Gram-positive pathogens. In animal studies and short-term human use, tedizolid lacks the hem
Externí odkaz:
https://doaj.org/article/8503783abf06477990e465182397946d
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 279-287 (2023)
Tianhui Gao,1,* Cong Yao,1,* Yuanyuan Shang,1 Renchun Su,1 Xuxia Zhang,1 Weicong Ren,1 Shanshan Li,1 Wei Shu,2 Yu Pang,1 Qi Li2 1Department of Bacteriology and Immunology, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beiji
Externí odkaz:
https://doaj.org/article/c56701577d834cb381b326f4fb7a943d
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 30, Iss , Pp 395-398 (2022)
Objectives: The aim of this study is to compare the in vitro activity and minimal inhibitory concentration (MIC) distributions of tedizolid and linezolid against Mycobacterium avium complex (MAC) strains using a reference broth microdilution assay an
Externí odkaz:
https://doaj.org/article/6d721a2ba6a641569eb982d909e2a448
Autor:
Fei Liu, Sajad Rajabi, Chunhua Shi, Ghazale Afifirad, Nazanin Omidi, Ebrahim Kouhsari, Saeed Khoshnood, Khalil Azizian
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Methicillin-resistant Staphylococcus aureus (MRSA) infections are considered an important public health problem, and treatment options are limited. Accordingly, in this meta-analysis, we analyzed published studies to survey in vit
Externí odkaz:
https://doaj.org/article/aba8353b4b6b4af98eef4f440ac6cb75
Publikováno v:
Infection and Drug Resistance, Vol Volume 15, Pp 4845-4852 (2022)
Huiyun Zhang,1 Wenya Hua,1 Siran Lin,1 Yu Zhang,1 Xinchang Chen,1 Shiyong Wang,1 Jiazhen Chen,1 Wenhong Zhang1– 3 1Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical
Externí odkaz:
https://doaj.org/article/e2d0d9df45cd4068a2a8fc31fc3e849f
Autor:
Gianpiero Tebano, Irene Zaghi, Francesco Baldasso, Chiara Calgarini, Roberta Capozzi, Caterina Salvadori, Monica Cricca, Francesco Cristini
Publikováno v:
Pathogens, Vol 13, Iss 1, p 88 (2024)
Antibiotic resistance in Gram-positive pathogens is a relevant concern, particularly in the hospital setting. Several antibiotics are now available to treat these drug-resistant pathogens, such as daptomycin, dalbavancin, linezolid, tedizolid, ceftar
Externí odkaz:
https://doaj.org/article/fa996f3b3daf4feda915db6da927a64f